Comparative effects of glucagon-like peptide-1 receptors agonists, 4-dipeptidyl peptidase inhibitors, and metformin on metabolic syndrome

Colaboración

Año: 2023

Bouzas, C; Pastor, R; Garcia, S; Monserrat-Mesquida, M; Martínez-González, MA; Salas-Salvadó, J; Corella, D; Goday, A; Martínez, JA; Alonso-Gómez, AM; Fernández-Barceló, O; Vioque, J; Romaguera, D; Lopez-Miranda, J; Estruch, R; Tinahones, FJ; Lapetra, J;

Título: BIOMEDICINE & PHARMACOTHERAPY

• Q1